The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMyhlth Chck Regulatory News (MHC)

Share Price Information for Myhlth Chck (MHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.00
Bid: 9.50
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 1.00 (10.526%)
Open: 10.00
High: 10.00
Low: 10.00
Prev. Close: 10.00
MHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

14 Oct 2022 07:00

RNS Number : 8525C
MyHealthChecked PLC
14 October 2022
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

Grant of Options

 

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that share options ("Options") over 16,000,000 ordinary shares of the Company have been granted to the Executive Directors under the 2016 EMI Share Option Scheme at an exercise price of 1.6p per share (being the closing price of the shares on 13 October 2022) as detailed below:

 

Name of Director

Number of Options Granted

Penelope McCormick, CEO

10,000,000 (Unapproved)

Nicholas Edwards, CFO

6,000,000

 

For both Executive Directors, the Options will vest in three equal tranches on 13 October 2023, 13 October 2024 and 13 October 2025. Each option is exercisable into one ordinary share and once vested, can be exercised up until 13 October 2032.

 

These new options represent approximately 2.05 per cent of the Company's current issued share capital. In total 42,084,600 options are now outstanding, representing approximately 5.39 per cent of the Company's current issued share capital.

 

For further information contact:

 

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR

Nicholas Edwards, Chief Financial Officer

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com

Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Anna Dunphy

Mob: +44(0)7876 741 001

 

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

 

 

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests, supported by a user-friendly digital interface..

 

MyHealthChecked is the umbrella brand of a range of at-home wellness tests that are available online, and will be viable for over-the-counter purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name

 

 

Penelope McCormick

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification/amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MyHealthChecked PLC

 

b)

 

LEI

 

 

213800RBHY6LZDG13168

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification code

GB00BYZ2R301

b)

 

Nature of the transaction

 

 

Grant of share options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.6 pence

10,000,000

d)

 

Aggregated information

- Aggregated volume

n/a

- Price

e)

 

Date of the transaction

 

 

13 October 2022

f)

 

Place of the transaction

 

 

Off market transaction

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name

 

 

Nicholas Edwards

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification/amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MyHealthChecked PLC

 

b)

 

LEI

 

 

213800RBHY6LZDG13168

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification code

GB00BYZ2R301

b)

 

Nature of the transaction

 

 

Grant of share options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.6 pence

6,000,000

d)

 

Aggregated information

- Aggregated volume

n/a

- Price

e)

 

Date of the transaction

 

 

13 October 2022

f)

 

Place of the transaction

 

 

Off market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEXLFFLBLZFBX
Date   Source Headline
7th Jul 20219:06 amRNSSecond Price Monitoring Extn
7th Jul 20219:01 amRNSPrice Monitoring Extension
7th Jul 20217:00 amRNSTrading update
2nd Jul 202111:08 amRNSSecond Price Monitoring Extn
2nd Jul 202111:02 amRNSPrice Monitoring Extension
2nd Jul 20219:03 amRNSPrice Monitoring Extension
29th Jun 202111:15 amRNSResult of AGM
28th Jun 20217:00 amRNSAcquisition of genetic testing & nutrition company
25th Jun 20214:43 pmRNSSecond Price Monitoring Extn
25th Jun 20214:36 pmRNSPrice Monitoring Extension
25th Jun 20212:06 pmRNSSecond Price Monitoring Extn
25th Jun 20212:00 pmRNSPrice Monitoring Extension
4th Jun 20217:02 amRNSNotice of Annual General Meeting
4th Jun 20217:01 amRNSBoard Changes
4th Jun 20217:00 amRNSPreliminary Results
1st Jun 20214:42 pmRNSSecond Price Monitoring Extn
1st Jun 20214:37 pmRNSPrice Monitoring Extension
1st Jun 20212:07 pmRNSSecond Price Monitoring Extn
1st Jun 20212:01 pmRNSPrice Monitoring Extension
1st Jun 202111:06 amRNSSecond Price Monitoring Extn
1st Jun 202111:02 amRNSPrice Monitoring Extension
20th May 20212:23 pmRNSRelated Party Transaction
17th May 20217:00 amRNSAdditional Boots agreement for D2/D8 testing
29th Apr 20212:00 pmRNSPrice Monitoring Extension
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:37 pmRNSPrice Monitoring Extension
6th Apr 20212:30 pmRNSDirectorate Change
6th Apr 20212:06 pmRNSSecond Price Monitoring Extn
6th Apr 20212:01 pmRNSPrice Monitoring Extension
6th Apr 20211:54 pmRNSAgreement with Boots for COVID-19 sample kits
29th Mar 20214:41 pmRNSSecond Price Monitoring Extn
29th Mar 20214:37 pmRNSPrice Monitoring Extension
29th Mar 20214:00 pmRNSFurther COVID-19 Government testing approvals
9th Mar 202112:15 pmRNSTR-1: Notification of major holdings
9th Mar 202111:06 amRNSSecond Price Monitoring Extn
9th Mar 202111:01 amRNSPrice Monitoring Extension
2nd Mar 20219:06 amRNSSecond Price Monitoring Extn
2nd Mar 20219:02 amRNSPrice Monitoring Extension
1st Mar 202111:06 amRNSSecond Price Monitoring Extn
1st Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 202110:00 amRNSComment on Share Price Movement
24th Feb 20212:27 pmRNSTR-1: Notification of major holdings
19th Feb 20219:53 amRNSDirector/PDMR Shareholding
18th Feb 20214:41 pmRNSSecond Price Monitoring Extn
18th Feb 20214:37 pmRNSPrice Monitoring Extension
18th Feb 202111:25 amRNSResult of General Meeting
18th Feb 20219:05 amRNSSecond Price Monitoring Extn
18th Feb 20219:00 amRNSPrice Monitoring Extension
17th Feb 20214:40 pmRNSSecond Price Monitoring Extn
17th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.